Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences, Inc. (RNA) Other Non-Current Liabilities (2019)

Avidity Biosciences' Other Non-Current Liabilities history spans 1 years, with the latest figure at $45000.0 for Q4 2019.

  • For Q4 2019, Other Non-Current Liabilities changed N/A year-over-year to $45000.0; the TTM value through Dec 2019 reached $45000.0, changed N/A, while the annual FY2019 figure was $45000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities reached $45000.0 in Q4 2019 per RNA's latest filing.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $45000.0 in Q4 2019 to a low of $45000.0 in Q4 2019.